Incorporation of unnatural nucleotides and methods thereof

US12319944B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12319944-B2
Application numberUS-202318481086-A
CountryUS
Kind codeB2
Filing dateOct 4, 2023
Priority dateJul 11, 2017
Publication dateJun 3, 2025
Grant dateJun 3, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing a protein comprising an unnatural amino acid in a cell, the method comprising: contacting the cell with an unnatural amino acid, the cell comprising: (i) a nucleoside triphosphate transporter from Phaeodactylum tricornutum; (ii) a tRNA from Methanosarcina mazei or Methanococcus jannaschii comprising an anticodon, the anticodon comprising an unnatural nucleotide comprising a first unnatural nucleobase independently selected from: (iii) an aminoacyl tRNA synthetase characterized in that it aminoacylates the tRNA with the unnatural amino acid; (iv) an mRNA encoding the protein comprising the unnatural amino acid and comprising a codon, the codon comprising an unnatural nucleotide comprising a second unnatural nucleobase independently selected from: wherein the anticodon of the tRNA pairs with the codon of the mRNA; wherein the mRNA is translated in the cell involving the tRNA, thereby producing a protein comprising the unnatural amino acid. 2. The method of claim 1 , further comprising introducing an unnatural nucleotide into the cell via the nucleoside triphosphate transporter. 3. The method of claim 1 , wherein the first unnatural nucleobase or the second unnatural nucleobase is 4. The method of claim 1 , wherein the second unnatural nucleobase is and the first unnatural nucleobase is 5. The method of claim 1 , wherein the anticodon comprises the sequence GYU or GYC, wherein Y is an unnatural nucleotide comprising the first unnatural nucleobase. 6. The method of claim 5 , wherein Y is an unnatural nucleotide comprising the first unnatural nucleobase, which is 7. The method of claim 1 , wherein the aminoacyl tRNA synthetase is from Methanosarcina barkeri or Methanococcus jannaschii. 8. The method of claim 1 , wherein the cell is a microorganism or bacterium. 9. The method of claim 1 , wherein the cell is E. coli. 10. A method of producing a protein comprising an unnatural amino acid in a cell, the method comprising contacting the cell with at least one unnatural nucleotide and at least one unnatural amino acid, the cell comprising: (i) a nucleoside triphosphate transporter from Phaeodactylum tricornutum; (ii) a tRNA from Methanosarcina mazei or Methanococcus jannaschii comprising an anticodon, the anticodon comprising an unnatural nucleotide comprising a first unnatural nucleobase independently selected from: (iii) an aminoacyl tRNA synthetase characterized in that it aminoacylates the tRNA with the unnatural amino acid; (iv) a nucleic acid encoding an mRNA encoding the protein comprising the unnatural amino acid and comprising a codon, the codon comprising an unnatural nucleotide comprising a second unnatural nucleobase independently selected from: wherein the anticodon of the tRNA pairs with the codon of the mRNA wherein: (a) the at least one unnatural nucleotide independently comprises the first nucleobase or the second nucleobase: (b)(i) the mRNA comprising the codon is synthesized by transcription and the at least one unnatural nucleotide comprising the second nucleobase is incorporated into the mRNA during transcription; and/or (ii) the tRNA comprising the anticodon is synthesized by transcription and the at least one unnatural nucleotide comprising the first nucleobase is incorporated into the tRNA during transcription; and (c) the mRNA is translated into the cell involving the tRNA, thereby producing a protein comprising the unnatural amino acid. 11. The method of claim 10 , wherein the at least one unnatural nucleotide is introduced into the cell via the nucleoside triphosphate transporter and is incorporated into the mRNA and/or the tRNA during transcription. 12. The method of claim 10 , wherein the first unnatural nucleobase or the second unnatural nucleobase of the unnatural nucleotide in the anticodon or the codon is and/or wherein the unnatural nucleobase of the unnatural nucleotide in the mRNA is and the unnatural nucleobase of the unnatural nucleotide in the tRNA is and/or wherein the anticodon comprises the sequence GYU or GYC, wherein Y is an unnatural nucleotide comprising the first unnatural nucleobase. 13. The method of claim 12 , wherein Y is an unnatural nucleotide comprising the first unnatural nucleobase, which is 14. The method of claim 10 , wherein the cell is a microorganism or bacterium. 15. The method of claim 10 , wherein the cell is E. coli. 16. The method of claim 1 , wherein at least one or both of the first unnatural nucleobase and the second unnatural nucleobase are each independently selected from: 17. The method of claim 1 , wherein at least one or both of the first unnatural nucleobase and the second unnatural nucleobase are each independently selected from: 18. The method of claim 1 , wherein the codon comprises the sequence AXC or GXC, wherein X is an unnatural nucleotide comprising the second unnatural nucleobase. 19. The method of claim 18 , wherein X is an unnatural nucleotide comprising the second unnatural nucleobase, which is 20. The method of claim 1 , wherein the unnatural amino acid is p-azido-phenylalanine (pAzF) or N 6 -[(2-propynyloxy) carbonyl]-l-lysine (PrK). 21. The method of claim 10 , further comprising expressing the aminoacyl tRNA synthetase from a plasmid in the ce

Assignees

Inventors

Classifications

  • Stable introduction of foreign DNA into chromosome · CPC title

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • Pyrrolysine-tRNAPyl ligase (6.1.1.26) · CPC title

  • C12P21/02Primary

    having a known sequence of two or more amino acids, e.g. glutathione · CPC title

  • C12N9/93Primary

    Ligases (6) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12319944B2 cover?
Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
Who is the assignee on this patent?
Synthorx Inc, Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C12P21/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).